PSIL holdings
AdvisorShares Psychedelics ETF
Positions
32 stored of 32 reported, largest first by weight
| # | Holding | ISIN | CUSIP | Weight | Value (USD) | Type | Issuer type | Country | Currency |
|---|---|---|---|---|---|---|---|---|---|
| 1 | DEFINIUM THERAPEUTICS INC DEFINIUM THERAPEUTICS INC COM SHS | CA24477V1058 | 24477V105 | 12.851% | $5.7M | Equity (common) | Corporate | Canada | USD |
| 2 | COMPASS PATHWAYS PLC COMPASS PATHWAYS PLC SPONSORED ADS | US20451W1018 | 20451W101 | 11.454% | $5.1M | Equity (common) | Corporate | United Kingdom | USD |
| 3 | ATAIBECKLEY INC ATAIBECKLEY INC COM SHS | US04650F1012 | 04650F101 | 10.472% | $4.7M | Equity (common) | Corporate | United States | USD |
| 4 | RELMADA THERAPEUTICS INC RELMADA THERAPEUTICS INC COM | US75955J4022 | 75955J402 | 6.836% | $3.0M | Equity (common) | Corporate | United States | USD |
| 5 | NRX PHARMACEUTICALS INC NRX PHARMACEUTICALS INC COM NEW | US6294442099 | 629444209 | 6.067% | $2.7M | Equity (common) | Corporate | United States | USD |
| 6 | NEUROCRINE BIOSCIENCES INC NEUROCRINE BIOSCIENCES INC COM | US64125C1099 | 64125C109 | 4.382% | $1.9M | Equity (common) | Corporate | United States | USD |
| 7 | CYBIN INC CYBIN INC COM NEW | CA23256X4075 | 23256X407 | 4.355% | $1.9M | Equity (common) | Corporate | Canada | USD |
| 8 | GH RESEARCH PLC GH RESEARCH PLC ORDINARY SHARES | IE000GID8VI0 | Not reported | 4.312% | $1.9M | Equity (common) | Corporate | Ireland | USD |
| 9 | ALKERMES PLC ALKERMES PLC SHS | IE00B56GVS15 | Not reported | 4.297% | $1.9M | Equity (common) | Corporate | Ireland | USD |
| 10 | ALTO NEUROSCIENCE INC ALTO NEUROSCIENCE INC COM SHS | US02157Q1094 | 02157Q109 | 4.202% | $1.9M | Equity (common) | Corporate | United States | USD |
| 11 | ABBVIE INC ABBVIE INC COM | US00287Y1091 | 00287Y109 | 4.145% | $1.8M | Equity (common) | Corporate | United States | USD |
| 12 | BLACKROCK TREASURY TRUST | Not reported | Not reported | 3.969% | $1.8M | Short-term investment vehicles (cash funds) | Registered fund | United States | USD |
| 13 | BRIGHT MINDS BIOSCIENCES INC BRIGHT MINDS BIOSCIENCES INC COM NEW | CA10919W4056 | 10919W405 | 3.835% | $1.7M | Equity (common) | Corporate | Canada | USD |
| 14 | JOHNSON & JOHNSON JOHNSON & JOHNSON COM | US4781601046 | 478160104 | 3.606% | $1.6M | Equity (common) | Corporate | United States | USD |
| 15 | DREY INST PREF GOV MM-M | Not reported | Not reported | 3.104% | $1.4M | Short-term investment vehicles (cash funds) | Registered fund | United States | USD |
| 16 | SUPERNUS PHARMACEUTICALS INC SUPERNUS PHARMACEUTICALS INC COM | US8684591089 | 868459108 | 2.891% | $1.3M | Equity (common) | Corporate | United States | USD |
| 17 | NEUPHORIA THERAPEUTICS INC NEUPHORIA THERAPEUTICS INC COM | US64136E1029 | 64136E102 | 2.488% | $1.1M | Equity (common) | Corporate | United States | USD |
| 18 | NEURONETICS INC NEURONETICS INC COM | US64131A1051 | 64131A105 | 2.173% | $966K | Equity (common) | Corporate | United States | USD |
| 19 | QUANTUM BIOPHARMA LTD QUANTUM BIOPHARMA LTD CL B SUB VTG SHS | CA74764Y2050 | 74764Y205 | 1.659% | $737K | Equity (common) | Corporate | Canada | USD |
| 20 | OPTIMI HEALTH CORP OPTIMI HEALTH CORP COMMON SHARES | CA68405H3080 | 68405H308 | 1.178% | $523K | Equity (common) | Corporate | Canada | USD |
| 21 | PASITHEA THERAPEUTICS CORP PASITHEA THERAPEUTICS CORP COM NEW | US70261F2020 | 70261F202 | 1.088% | $483K | Equity (common) | Corporate | United States | USD |
| 22 | SILO PHARMA INC SILO PHARMA INC COM | US82711P3001 | 82711P300 | 1.056% | $469K | Equity (common) | Corporate | United States | USD |
| 23 | PSYENCE BIOMEDICAL LTD PSYENCE BIOMEDICAL LTD COM SHS | CA74449F4078 | 74449F407 | 0.842% | $374K | Equity (common) | Corporate | Canada | USD |
| 24 | INCANNEX HEALTHCARE INC INCANNEX HEALTHCARE INC COM | US45333F2083 | 45333F208 | 0.515% | $229K | Equity (common) | Corporate | United States | USD |
| 25 | NUMINUS WELLNESS INC NUMINUS WELLNESS INC COM | CA67054W1032 | 67054W103 | 0.471% | $209K | Equity (common) | Corporate | Canada | USD |
| 26 | IGC PHARMA INC IGC PHARMA INC COM NEW | US45408X3089 | 45408X308 | 0.415% | $185K | Equity (common) | Corporate | United States | USD |
| 27 | VISTAGEN THERAPEUTICS INC VISTAGEN THERAPEUTICS INC COM | US92840H4002 | 92840H400 | 0.223% | $99K | Equity (common) | Corporate | United States | USD |
| 28 | ENVERIC BIOSCIENCES INC ENVERIC BIOSCIENCES INC COM SHS | US29405E5050 | 29405E505 | 0.110% | $49K | Equity (common) | Corporate | United States | USD |
| 29 | CLEARMIND MEDICINE INC CLEARMIND MEDICINE INC COM SHS | CA1850536006 | 185053600 | 0.006% | $3K | Equity (common) | Corporate | Canada | USD |
| 30 | QUANTUM BIOPHARMA | Not reported | Not reported | 0.000% | $0 | Equity (common) | Corporate | Canada | CAD |
| 31 | SAGE THERAPEUTICS INC | Not reported | Not reported | 0.000% | $0 | Equity (common) | Corporate | United States | USD |
| 32 | UNBUZZD WELLNESS INC UNBUZZD WELLNESS INC N/C FROM QUANTUM BIOPHARMA LTD TO UNBUZZ | CA90429T1003 | 90429T100 | 0.000% | $0 | Equity (common) | Corporate | Canada | CAD |